Brevan Howard Boosts Stake in Hologic

Hedge fund increases position in medical equipment maker by 163.6%

Mar. 17, 2026 at 8:19am

Got story updates? Submit your updates here. ›

Brevan Howard Capital Management LP raised its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 163.6% in the 3rd quarter, according to the company's SEC filing. The hedge fund now owns 46,737 shares of the medical equipment provider's stock, worth $3.15 million.

Why it matters

Hologic is a major player in the medical technology industry, specializing in women's health products like digital mammography systems and molecular diagnostics. Brevan Howard's increased stake suggests the hedge fund sees growth potential in the company.

The details

Brevan Howard Capital Management LP added 29,009 shares to its Hologic position during the third quarter, bringing its total holdings to 46,737 shares. The hedge fund's increased stake comes as Hologic has seen its stock price rise over the past year, reaching a 52-week high of $75.75 in November.

  • Brevan Howard increased its Hologic stake in the 3rd quarter of 2025.

The players

Brevan Howard Capital Management LP

A global macro hedge fund based in the United Kingdom that manages over $20 billion in assets.

Hologic, Inc.

A medical technology company specializing in women's health products such as digital mammography systems and molecular diagnostics.

Got photos? Submit your photos here. ›

The takeaway

Brevan Howard's increased stake in Hologic suggests the hedge fund sees strong growth potential in the medical equipment provider, particularly in its women's health product lines. This could signal positive momentum for Hologic as it continues to innovate and expand its market share.